Loading, Please Wait...
MOUNTAIN VIEW, Calif., April 01, 2019 (GLOBE NEWSWIRE) -- IRIDEX Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases, announced today that its Cyclo G6® Glaucoma Laser and proprietary MicroPulse® Technology was featured in various posters and presentations at the World Glaucoma Congress last week in Melbourne, Australia. The congress ran from March 27- 31, 2019.
Eight world-renowned glaucoma specialists provided hands-on training with the Cyclo G6 Glaucoma Laser to 50 physicians at a wet lab on Friday, March 29th. Additionally, Prof. Paul Chew (Singapore), Dr. Ziad Khoueir (Lebanon), Dr. Shan Lin (United States), Dr. Robert Chang (United States), Dr. Sandra Sieminski (United States), Dr. Victor Koh (Singapore), Dr. Cecilia Aquino (Singapore) and Dr. Ilesh Patel (Australia) provided training, discussed cases, results, technique, and best practices.
At the IRIDEX booth, six MicroPulse laser experts (Dr. Ziad Khouer, Dr. Sandra Sieminski, Dr. Shan Lin, Dr. Robert Chang, Dr. Sheng Lim, and Dr. Vital Paulino Costa) shared experiences, results and best practices with attendees.
The following are some of the symposiums, courses, abstracts and posters where World Glaucoma Congress attendees learned about MicroPulse laser therapy for glaucoma:
IRIDEX is a worldwide leader in developing innovative and versatile laser-based medical systems, delivery devices and consumable instrumentation for the ophthalmology market. The Company’s proprietary MicroPulse® technology delivers a differentiated treatment that provides safe, effective, and proven treatment for targeted sight-threatening eye conditions. IRIDEX’s current product line is used for the treatment of glaucoma, diabetic macular edema (DME) and other retinal diseases. IRIDEX products are sold in the United States and Germany through a direct sales force and in more than 100 countries through a network of independent distributors. For more information, visit http://www.iridex.com.
Investor Relations Contact:
Pascale Communications, LLC.